Title : PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mice.

Pub. Date : 2021 Dec

PMID : 34785428






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mice. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
2 Here we investigated the potential anti-atherogenic effect of PRMT4 inhibitor TP-064 in vivo. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
3 CONCLUSIONS: The PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing atherosclerosis susceptibility of male apolipoprotein E knockout mice. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus